MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma

72Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

MiR-106b is frequently up-regulated in various types of human cancer including laryngeal carcinoma. However the underlying mechanism of miR-106b involved in laryngeal carcinoma remains elusive. Here we showed that reduction of miR-106b induced cell cycle G0/G1 arrest by targeting tumor suppressor RB in human laryngeal carcinoma cells. Further, Introducing RB cDNA without 3'UTR abrogated miR-106b-induced cell proliferation. Finally, there was an inverse relationship between RB and miR-106b expression in laryngeal carcinoma tissues. To our knowledge, these data indicate for the first time that miR-106b directly regulate cell cycle by targeting RB in laryngeal carcinoma and that miR-106b could be potential therapeutic approaches for laryngeal carcinoma. © 2011 Cai et al; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Cai, K., Wang, Y., & Bao, X. (2011). MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma. Journal of Experimental and Clinical Cancer Research, 30(1). https://doi.org/10.1186/1756-9966-30-73

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free